Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117311) titled 'Observational Study of Clinical Therapy for Renal Anemia' on Jan. 22.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: West China Hospital of Sichuan University
Condition:
Chronic kidney disease
Intervention:
ESA group: Erythropoietin treatment group:NA
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-01
Target Sample Size: ESA group: Erythropoietin treatment group:87;HFI-PHI group: treatment group using roxatidine or enadoxine:87;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=305990
Di...